Trials / Unknown
UnknownNCT00999973
Study on the Effect of Mitomycin C 0.02% on the Corneal Endothelial After Photorefractive Keratectomy in Moderate Myopia
- Status
- Unknown
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- —
- Sponsor
- Shahid Beheshti University of Medical Sciences · Academic / Other
- Sex
- All
- Age
- 19 Years – 60 Years
- Healthy volunteers
- —
Summary
In this study 126 eyes in 63 patients with moderate bilateral myopia and astigmatism between -3 and -5 (SE difference between two eyes should not be more than 0.75 and the residual corneal thickness\>350 μ ) were entered in the study. One eye went randomly under PRK with mitomycin C 0.02% in 15 min and then the other eye went under the operation without MMC. UCVA,BCVA, refractory error after the operation and the number of endothelial cells before and after the surgery would be compared in 6 months.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Mitomycin C 0.02% | |
| DRUG | Placebo |
Timeline
- Start date
- 2009-09-01
- First posted
- 2009-10-22
- Last updated
- 2009-10-22
Locations
1 site across 1 country: Iran
Source: ClinicalTrials.gov record NCT00999973. Inclusion in this directory is not an endorsement.